Doctors say there are less invasive screening options for colon cancer, but each comes with tradeoffs.

Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted ...

An estimated 52,500 Americans died last year from colon cancer, yet the disease is highly treatable if it's detected early. Primary care and prevention experts from the U.S. Preventive Services Task ...

The survey results reveal strong enthusiasm for blood-based screening options among adults aged 45 and older, the group ...

A patient who had repeatedly refused routine screening for colorectal cancer (CRC), despite having lost his 80-year-old father to the disease, was again advised to undergo a colonoscopy at age 56. He ...

Please provide your email address to receive an email when new articles are posted on . Colonoscopy is most sensitive for CRC, but offering patients choices like FIT can improve screening rates. New ...

A new study from Oakland, Calif.-based Kaiser Permanente found that patients who receive a positive fecal test often delay undergoing colonoscopy – the recommended procedure following a positive ...

Stool-based DNA testing can help bridge CRC screening gaps between rural and urban populations by providing timely follow-up. The study found no significant difference in follow-up times for ...

A next-generation multitarget stool DNA test, including assessments of DNA molecular markers and hemoglobin level, was developed to improve the performance of colorectal cancer screening, primarily ...

Offering colorectal cancer (CRC) screening to patients when they come to the clinic for wellness visits may be the standard of care, but relying on that strategy alone will miss many patients who do ...

Very few people look forward to their first colonoscopy once they reach 45 years old, the age at which colon cancer screening should begin for people at average risk. That is one of the reasons ...